Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Open access

Abstract

The NINCDS-ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge. Distinctive and reliable biomarkers of AD are now available through structural MRI, molecular neuroimaging with PET, and cerebrospinal fluid analyses. This progress provides the impetus for our proposal of revised diagnostic criteria for AD. Our framework was developed to capture both the earliest stages, before full-blown dementia, as well as the full spectrum of the illness. These new criteria are centred on a clinical core of early and significant episodic memory impairment. They stipulate that there must also be at least one or more abnormal biomarkers among structural neuroimaging with MRI, molecular neuroimaging with PET, and cerebrospinal fluid analysis of amyloid beta or tau proteins. The timeliness of these criteria is highlighted by the many drugs in development that are directed at changing pathogenesis, particularly at the production and clearance of amyloid beta as well as at the hyperphosphorylation state of tau. Validation studies in existing and prospective cohorts are needed to advance these criteria and optimise their sensitivity, specificity, and accuracy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(07)70178-3

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 143 references

Research works printed but not linked: 2

  1. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC. Qualitative estimates of medial temporal atrophy predict progression of mild cognitive impairment to dementia. Arch Neurol (in press).
  2. 1997, The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, Neurobiol Aging, 18, S1

Cited by

See all 4,411

Metadata

Authors
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P. J., & Scheltens, P.
Affiliations
  • Inserm (FR)
  • Vancouver Coastal Health (CA)
  • University of Pittsburgh (US)
  • University of California, Los Angeles (US)
  • University of California San Diego (US)
  • Douglas Mental Health University Institute (CA)
  • University of Kentucky (US)
  • Tohoku University (JP)
  • Newcastle upon Tyne Hospital (GB)
  • Centre Hospitalier Universitaire de Lille (FR)
  • Hôpital Pasteur (FR)
  • UCL Queen Square Institute of Neurology (GB)
  • NewYork–Presbyterian Hospital (US)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Dubois, Bruno
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2007-08
Volume
6
Issue
8
Pages
734-746
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2106931873
Cited by
4,411
References
143
Citations by year
2026: 89 · 2025: 153 · 2024: 196 · 2023: 160 · 2022: 161 · 2021: 193 · 2020: 282 · 2019: 208 · 2018: 226 · 2017: 229 · 2016: 241 · 2015: 270 · 2014: 308 · 2013: 307 · 2012: 364
FWCI
27.46
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
Alzheimer's disease, diagnostic criteria, NINCDS-ADRDA criteria, DSM-IV-TR diagnostic criteria, episodic memory impairment, amyloid-beta, tau protein, cerebrospinal fluid biomarkers, structural MRI, preclinical Alzheimer's disease, early diagnosis
MeSH terms
Alzheimer Disease, Diagnostic Imaging, Humans, Memory Disorders, National Institutes of Health (U.S.), Severity of Illness Index, Time Factors, United States, Amyloid beta-Peptides, tau Proteins, Disease Progression, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. https://app.cochat.ai/papers/10.1016/s1474-4422(07)70178-3
The paper
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P. J., & Scheltens, P. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(07)70178-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.